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Objectives: Dynamic cardiomyoplasty is an alternative therapy for end-stage 
heart failure. We investigated the mechanisms, both acute and chronic, by 
which a synchronously stimulated conditioned muscle wrap affects left 
ventricular function in a chronic canine model of dilated cardiomyopathy. 
Methods: Nineteen dogs underwent rapid ventricular pacing at a rate of 215 
beats/min for 4 weeks to create a model of heart failure. Eight dogs were 
then randomly selected to undergo cardiomyoplasty, and all dogs received 
6 additional weeks of rapid ventricular pacing. The cardiomyoplasty group 
also received a graded muscle conditioning protocol of synchronized burst 
stimulation to transform the muscle wrap. All dogs were studied with 
pressure-volume analysis and echocardiography atbaseline and after 4 and 
10 weeks of rapid ventricular pacing. Data in the cardiomyoplasty group 
were analyzed with the stimulator off, with i! augmenting every beat (1:1). 
and with it augmenting only every other beat (1:2). Results: Stimulator "off" 
data at 10 weeks of rapid pacing demonstrated chronic effects by enhanced 
ventricular function (end-systolic elastance = 1.80 after myoplasty vs 1.17 
for controls, p = 0.005"1 and a stabilization of volumes and composite 
end-systolic and end-diastolic pressure-volume relations in the cardiomy- 
oplasty group when compared with controls. Myoplasty stimulation in- 
creased apparent contractility (preload recruitable stroke work = 31.3 for 
stimulator "off" vs 40.6 for stimulator 1:2 assisted beats [p < 0.05] and vs 
45.4 for stimulator 1:1 [p < 0.05]). Conclusions: Benefits from dynamic 
cardiomyoplasty are by at least two mechanisms: (1) the girdling effects of 
a conditioned muscle wrap, which halts the chronic remodeling of heart failure, 
and (2) active systolic assistance, which augments the apparent contractility of 
the failing heart. (J Thorac Cardiovasc Surg 1997;114:169-78) 
Di cnamic cardiomyoplasty is a surgical option de- ~ised for the treatment of patients with end- 
stage heart failure. In this procedure, the latissimus 
dorsi muscle is mobilized and wrapped circumferen- 
tially around the heart and is then stimulated syn- 
chronously with cardiac systole so that it can assist 
the failing myocardium. 1 Preliminary results from 
the Food and Drug Administration's phase II trial 
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on cardiomyoplasty have shown beneficial effects on 
patient symptoms and cardiac function. 2 The mech- 
anism of action of cardiomyoplasty is yet to be 
determined, and discordant results on its effects on 
hemodynamics and cardiac function have been re- 
ported. Some studies have shown minimal effects of 
dynamic assistance, 3-5 whereas others have docu- 
mented improvement in function with added dy- 
namic compression. 6-14 Recently, some authors have 
suggested that the main mechanism of action may 
be a girdling effect of the muscle wrap, with ventric- 
ular volumes being stabilized by the presence of the 
wrap?' 15-17 
These conflicting results can be attributed to 
several reasons. Some studies have been performed 
with the use of unconditioned muscle wraps, and 
other experiments have been performed on normal 
hearts. Neither of these situations is clinically rele- 
vant, because significant phenotypic hanges occur 
169 
170 Patet et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
August 1997 
CONTROL 
(!l=l 1) 
CMP 
(.=s) 
II • • 
L " - . RVP  
I CMP Ill$[lIN]l[lllll$[lll[llllMuSCLE ON IIfH$lllINll[l[lltlllll[l[flIJ i 
m l 
', , 
i i 
BASELINE FOUR WEEKS TEN WEEKS 
ECHO/PVA BURST ST IMULATED MUSCLE 
CONDIT IONING PROTOCOL 
Fig. !, Experimental design. Our experimental protocol shows that 19 dogs underwent baseline pacemaker 
installation followed by rapid ventricular pacing (RVP) for 10 weeks at a rate of 215 beats/min to create heart 
failure. All dogs had pressure-volume analysis (PVA) and two-dimensional echocardiography (echo) studies at 
baseline and at 4 and 10 weeks of RVP. Eight dogs underwent cardiomyoplasty (CMP) at 4 weeks of RVP. The 
muscle conditioning protocol is a graded burst-stimulation protocol and is detailed in the text. 
in skeletal muscle with continuous electrical stimu- 
lation.4, 5, is, 19 In addition, the function of normal 
hearts is hard to improve. Studies have also fre- 
quently relied on the use of load-sensitive indices of 
function, which may not be able to discern relatively 
small differences in function. Finally, a number of 
studies have relied on traditional imaging methods 
that do not follow the translational motion out of 
the plane of imaging that occurs with dynamic 
cardiomyoplasty. 2° 
Our study was designed to assess the chronic 
effects on left ventricu!ar function of a synchronized 
burst-stimulated conditioned muscle wrap in a 
model of chronic dilated cardiomyopathy. 21 In ad- 
dition, we attempted to determine whether acute 
dynamic assistance was evident in the setting of 
heart failure using a transformed muscle wrap. We 
used the techniques of pressure-volume analysis and 
two-dimensional echocardiography to obtain load- 
sensitive and load-independent measures of myocar- 
dial function. These modalities also allowed us to 
assess long-term changes in left ventricular volumes. 
Method 
All dogs used in this study received care in compliance 
with the "Guide for Care and Use of Laboratory Animals" 
published by the National Institutes of Health (NIH 
publication 86-23, revised 1985), and the investigation was 
approved by the Institutional Animal Care and Use 
Committee of the University of Pennsylvania School of 
Medicine. 
Design of the study. Nineteen heartworm-free adult 
male mongrel dogs (25 to 30 kg) were used in this study. Two 
additional control dogs and three additional cardiomyo- 
plasty-treated dogs died during the course of rapid ventric- 
ular pacing and were thus not included in the final analysis. 
Most of the deaths occurred uring the initial development 
of the model. The protocol is shown schematically in Fig. 1. 
All dogs underwent baseline two-dimensional echocardiog- 
raphy and pressure-volume analysis as described below. 
After implantation of pacemakers, alldogs were subjected to 
rapid ventricular pacing at a rate of 215 beats/rain for 4 
weeks to ensure development ofcongestive heart failure. 
Studies were repeated to ensure development of car- 
diac dysfunction before randomization f eight dogs into 
the cardiomyoplasty group. All 19 dogs continued to 
undergo the rapid ventricular pacing protocol at 215 
beats/rain (uninterrupted) for an additional 6weeks. The 
eight dogs that had cardiomyoplasty also underwent a
concurrent conditioning protocol of graded burst stimu- 
lation of the latissimus dorsi muscle wrap during the 
ensuing weeks of rapid ventricular pacing. Final studies 
were performed at the end of the 10-week period. 
Medical therapy for all dogs consisted of daily digoxin 
(0.125 rag) and furosemide (20 rag), along with thrice 
weekly aspirin (81 rag) for the last 9 weeks of rapid 
ventricular pacing. 
Anesthesia. One hour before the operation, each ani- 
mal was premedicated intramuscularly with acepromazine 
(0.1 mg/kg) and glycopyrrolate (0.001 mg/kg). General 
anesthesia was induced with ketamine (10 mg/kg) and 
diazepam (0.5 mg/kg) intravenously and maintained after 
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Table I. Pressure-volume analysis: Baseline versus 4 weeks of  pacing 
Parameter 
Baseline Four weeks of RVP 
Control CMP p Value* Control CMP p Value* A Control? A CMP? 
Ees (mm Hg/ml) 3.14 ± 0.70 2.96 ± 1.51 0.72 1.68 + 0.89 1.38 ± 0.23 0.4 -46.5%$ 53.4%~ 
PRSW (mm Hg) 49.9 ± 3.4 58.7 -+ 7.5 0.003 34.6 ± 9.9 29.2 _+ 8.8 0.27 -30.7%-~ -50.3%:~ 
dP/dt max (mm Hg/sec) 1797 _+ 295 2133 ± 429 0.06 1280 + 686 952 ± 191 0.21 -28.8%~ -55.4%:~ 
Peak LVP (ram Hg) 94.7 _+ 9.5 100.2 _+ 10.4 0.24 87.1 _+ 14.3 74.0 ± 10.8 0.05 8.0% -26.1%:~ 
Heart rate (beats/min) 121.6 _+ 24.0 131.8 ± 25.2 0.38 123.8 _+ 18.0 112.6 ± 21.2 0.26 +0.02% -14.6% 
Tau (msec) 30.3 _+ 7.2 28.0 ± 7.9 0.53 46.6 ± 13.7 49.6 ± 13.8 0.66 +53.8%:~ +77.1% 
dP/dt rain (mm Hg/sec) -1810 ± 386 -2278 _+ 390 0.02 -1437 ± 581 -1105 _+ 264 0.16 +20.6%~+ 51.5%~ 
LVEDP (mm Hg) 5.2 +_ 1.9 4.9 ± 2.4 0.24 10.7 _+ 5.6 6.0 ± 2.7 0.05 +105.7%:~ +22.4% 
RVP, Rapid ventricular pacing; CMP, cardiomyoplasty; Ees, end-systolic elastance; PRSW, the slope of the preload recruitable stroke work line; dP/dt max 
and dP/dt rain, maximum and minimum rates of pressure change; LVP, left ventricular p essure; LVEDP, left ventricular end-diastolic pressure; Tau, the time 
constant of isovolumic pressure decay. All data are expressed asmean +- standard deviation. For the control group, pressure-volume data are available for 
9 of 11 dogs at 4 weeks of RVP; for the cardiomyoplasty group, volume data are available at 4 weeks for 7 of 8 dogs. 
*p Value by unpaired t-test comparing between control and synchronous wrap groups at that time point. 
?The delta columns express the percent change of a hemodynamic variable from baseline to 4 weeks of RVP as a fraction of the its baseline value. 
Sp < 0.05 by repeated-measures analysis of variance followed by Bonferroni's multiple comparison procedure comparing baseline data versus 4weeks' RVP 
data within each group. 
endotracheal intubation with inhaled oxygen (3 L/min) 
and isoflurane (1% to 2%). All dogs also received peri- 
operative antibiotics. 
Instrumentation and data collection. Standard two- 
dimensional transthoracic echocardiograms were ob- 
tained before each pressure-volume analysis with the 
animal awake. Short-axis and apical long-axis and four- 
chamber views were obtained and stored for later analysis. 
For the pressure-volume analysis, all dogs were placed 
under general anesthesia nd instrumented under sterile 
conditions as follows. A 7F multielectrode dual-field 
conductance catheter (Sentron Europe, Maastricht, The 
Netherlands) and a 5F micromanometer-t ipped catheter 
(Millar Instruments, Inc., Houston, Tex.) were placed 
under fluoroscopic guidance in the left ventricle via 
cutdowns on the right carotid and right femoral arteries. 
Similarly, 20 ml occlusion catheters (Applied Vascular, 
Laguna Hills, Calif.) were placed at the junction of the 
superior and inferior venae cavae with the right atrium via 
the right jugular and right femoral veins. A balloon-tipped 
pulmonary artery catheter was placed via the left jugular 
vein. Volume measurements were obtained by means of 
the conductance catheter technique. 22-24 All hemody- 
namic signals and the electrocardiogram tracing were 
processed, digitized at 500 Hz, and stored on computer 
disk for later analysis. 
All data were collected with the ventilator held at 
end-expiration. For determination of the end-systolic and 
end-diastolic pressure volume relationships (ESPVR and 
EDPVR,  respectively) and the preload recruitable stroke 
work relationship (PRSW), the 20 ml balloons in the 
venae cavae were temporarily inflated to diminish pre- 
load, as described previously. 23' 25-27 Each preload reduc- 
tion and steady-state data collection was performed a 
minimum of three times with at least 1 minute of recovery 
time between each sample collection. All incisions were 
then closed primarily. 
Pacemaker insertion. After a recovery period of no less 
than 3 days after the baseline pressure-volume analysis, 
each dog underwent placement of modified ventricular 
pacemakers (model 8341, Medtronics, Inc,, Minneapolis, 
Minn.) designed to maintain prolonged pacing rates at 
215 beats/min. Under general anesthesia, a 2 × 3 cm 
section of the apical pericardium was excised through a 
right anterior thoracotomy, and a unipolar pacing lead 
(model 6917A, Medtronics) was secured to the left ven- 
tricular apex. The lead was then tunneled subcutaneously 
to a subfascial abdominal pocket and connected to the 
pacemaker. All incisions were then closed and the pneu- 
mothorax was evacuated before extubation. Animals were 
allowed to recover for at least 7 days, after which pacing 
was initiated at a rate of 215 beats/min for 4 weeks. 
Cardiomyoplasty with the left latissimus dorsi muscle. 
After 4 weeks of rapid ventricular pacing, pressure- 
volume analysis and echocardiographic studies were re- 
peated as described earlier. Two control animals did not 
undergo pressure-volume analysis at 4 weeks but did 
undergo two-dimensional echocardiography. In addition, 
one dog ultimately randomized into the cardiomyoplasty 
group underwent echocardiography and catheterization 
for pressure measurements alone at 4 weeks of rapid 
ventricular pacing. Eight of the dogs were randomly 
selected to undergo cardiomyoplasty immediately after 
the 4-week rapid ventricular pacing catheterization. 
Through a left flank incision, the entire latissimus dorsi 
muscle was mobilized into a pedMe flap based entirely on 
the thoracodorsal neurovascular bundle. A neuromuscu- 
lar epimysial electrode (model NMS, Medtronics) was 
loosely secured over the thoracodorsal nerve just proximal 
to the trifurcation along the costal surface of the muscle. 
The mobilized muscle with its lead was then passed into 
the left hemithorax via a 5 cm window in the second rib 
and its humeral insertion was anchored to the periosteum 
of the first rib. A left thoracotomy through the fifth 
intercostal space was performed. The muscle was then 
wrapped posteriorly to anteriorly around both ventricles 
in a clockwise fashion (as viewed from the apex) and 
anchored to the surrounding pericardium and epicardium 
with interrupted pledget-supported monofilament su- 
tures. Adequate care was taken to avoid overstretching 
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Fig. 2. Echocardiographic results. These echocardiographic data demonstrate the chronic effects of 
cardiomyoplasty onventricular function and geometry. Notice that the initial 4 weeks of rapid ventricular 
pacing (RVP) increased volumes (EDV) and decreased ejection fraction (EF) in all dogs. In contrast o 
control dogs, in which this process continued for the last 6 weeks of rapid ventricular pacing, volumes and 
ejection fractions were stabilized in the cardiomyoplasty (CMP) group. Data represented for the 
cardiomyoplasty group are with the myostimulator "off" to assess chronic effects of cardiomyoplasty on the 
failing heart. A l lp values represent comparisons between 4 and 10 weeks of rapid ventricular pacing within 
each group. 
the muscle or tension on the neurovascular pedMe. The 
ventral border of the muscle was then anchored to the 
right ventricular epicardium with a running stitch. The 
lead was tunneled subcutaneously to a subfascial abdom- 
inal pocket and connected to the implantable cardiomyo- 
stimulator (model Transform). Once muscle threshold 
amplitudes were recorded and muscle stimulation was 
confirmed visually, the stimulator was turned off. A left 
thoracostomy tube and two subcutaneous drains were 
placed and all incisions were closed. The tube was re- 
moved after at least 1 hour of suction and before recovery 
from anesthesia. 
After a recovery period of no more than 3 days, rapid 
ventricular pacing was resumed in all dogs, and a concur- 
rent, graded, burst-stimulation muscle conditioning pro- 
tocol delivered in synchrony with cardiac systole was 
begun in the cardiomyoplasty group. 4 The cardiomyo- 
stimulator muscle settings were programmed to the fol- 
lowing: unipolar mode, pulse width of 198 /zsec, pulse 
interval of 31 msec, adaptation off, and the number of 
pulses per train (ppt) and synchronization ratio per the 
conditioning protocol. The pulse amplitude was initially 
set at twice threshold. Thereafter, the muscle was checked 
daily by palpation, and the amplitude was increased as 
required. The muscle conditioning protocol was as fol- 
lows: week 1, synchronization ratio of 1:4, muscle:heart- 
beat, with 1 ppt; week 2, ratio of 1:3 with 1 ppt; week 3, 
ratio of 1:3 with 2 ppt; week 4, ratio of 1:3 with 3 ppt; and 
weeks 5 and 6, ratio of 1:3 with 4 ppt. Final studies were 
performed after a total of 10 weeks rapid ventricular 
pacing (i.e., at the end of the conditioning protocol). In all 
dogs the pacemakers were turned off for collection of 
hemodynamic data. 
Data analysis. All hemodynamic data were analyzed 
off-line with custom software. The conductance catheter 
was calibrated by the saline method previously described 22
with the volume gain set to unity. Steady-state parameters 
that were obtained included heart rate, stroke volume, 
cardiac output, stroke work, peak left ventricular pressure 
and end-diastolic left ventricular pressure (LVEDP), max- 
imum and minimum rates of pressure change (maximum 
dP/dt and minimum dP/dt), pulmonary artery pressures, 
and the time constant of isovolumic pressure decay 
(tau). Tau was calculated as previously described. 28The 
ESPVR, the EDPVR, and the PRSW data were derived 
from the preload reduction data. All data in which the 
heart rate changed more than 5% were discarded to 
minimize the effects of cardiovascular reflexes. During 
collection of myostimulator "on" data, the adaptation 
was off, and the synchronization delay set so that the 
myostimulator delivered a 4 ppt burst stimulus just after 
closure of the mitral valve. The composite ESPVRs and 
EDPVRs were obtained as detailed in the appendix. 
Left ventricular volumes according to two-dimensional 
echocardiography were calculated by the modified bi- 
plane Simpson rule. 29 
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Fig. 3. Effects of rapid ventricular pacing (RVP) and cardiomyoplasty on composite pressure-volume 
relationships over time. A, The continued rightward shift in both end-systolic (ESPVR) and end-diastolic 
pressure-volume relations (EDPVR) over the 10-week RVP period in control dogs. This demonstrates that 
RVP does lead to long-term remodeling throughout the rapid pacing period in our control group. In 
contrast, in the dynamic ardiomyoplasty group (B), there is an initial rightward shift over the first 4 weeks 
of RVP only. Dynamic cardiomyoplasty stabilizes the remodeling process during the ensuing 6 weeks 
despite ongoing rapid pacing. The ESPVR and EDPVR shown in B represent curves obtained with the 
stimulator "off." The p values reflect he differences in position of the ESPVR between different ime 
points, as indicated by the end-systolic volume for an end-systolic pressure of 80 mm Hg. 
Statistical data were obtained with the use of standard 
software (SigmaStat, Jandel Scientific, San Rafael, Calif., 
and SPSS, SPSS Inc., Chicago, III). All data are expressed 
as mean _+ standard eviation. An unpaired t test was used 
to determine differences between control and cardiomyo- 
plasty groups. Analysis of variance with repeated mea- 
sures followed by the multiple comparison method of 
Bonferroni was used to detect differences between time 
points within each group. Finally, analysis of variance with 
repeated measures followed by the multiple comparison 
method of Dunnett was used to ascertain differences 
between data obtained with the various stimulator assist 
modes versus data obtained with the stimulator off. 
Results 
Pressure-volume data analysis for all dogs studied 
at baseline are shown in Table I. All measures of 
cardiac function except PRSW and maximum nega- 
tive rate of pressure change (minimum dP/dt) were 
similar. Volumes and ejection fractions by echocar- 
diography displayed no significant differences at 
baseline (Fig. 2). 
In the time-varying elastance model of the heart, 
cardiac pressure and volume traverse the pressure- 
volume plane within the limits of a specific ESPVR 
(representing systolic performance) and EDPVR 
(representing passive chamber properties)Y We 
generated composite ESPVRs and EDPVRs for 
each group at each time point (Fig. 3, A and B, and 
appendix). These curves allowed us to assess the 
changes in myocardial performance brought on both 
by rapid ventricular pacing and by cardiomyoplasty. 
The curves generated from baseline data (Fig. 3) 
showed a similar functional state. 
By 4 weeks of rapid ventricular pacing, left ven- 
tricular function deteriorated according to both 
load-independent and load-sensitive measures of 
myocardial performance in both groups (Table I). A 
comparison between groups showed that functional 
differences at baseline (PRSW and minimum alP/tit) 
were not present by 4 weeks of rapid ventricular 
pacing. Progressive pump failure and left ventricular 
remodeling was also seen in the composite ESPVRs 
for both groups (Fig. 3). LVEDP was not signifi- 
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Table II. Pressure-volume analysis: Four weeks versus 10 weeks of pacing 
Parameter 
Four weeks of RVP Ten weeks of RVP 
Control CMP Control CMP stim off p Value* A Control/ 2x CMP? 
Ees (mm Hg/ml) 1.68 ,+ 0.89 1.38 _+ 0.23 1.17 + 0.32 1.80 ,+ 0.53 0.005 -30.4%§ +30.4% 
PRSW (mm Hg) 34.6 _+ 9.9 29.2 _+ 8.8 26.3 .+ 4.5 31.3 ,+ 5.9 0.05 -24.0%:) +7.2% 
dP/dt max (mm Hg/sec) 1280 _+ 686 952 ,+ 191 873 .+ 192 985 _+ 230 0.26 -31.8%:) +3.5% 
Peak LVP (mm Hg) 87.1 _+ 14.3 74.0 _+ 10.8 79.0 ~- 9.4 84.1 ,+ 11.2 0.30 -9.3% +13.6% 
Heart rate (beats/min) 123.8 _+ 18.0 112.6 ,+ 21.2 115.2 ,+ 12.4 115.2 _+ 20.2 0.71 -6.9% +2.3% 
Tau (msec) 46.6 ,+ 13.7 49.6 _+ 13.8 62.4 + 9.0 66.6 + 26.5 0.63 +33.9%:) +34.3%:) 
dP/dt min (mm Hg/sec) -1437 _+ 581 -1105 _+ 264 -1007 ± 227 -1123 _+ 310 0.36 +29.9%:) +1.6% 
LVEDP (ram Hg) 10.7 + 5.6 6.0 .+ 2.7 17.0 ,+ 5.1 11.2 _+ 8.2 0.07 +58.9%:) +86.7% 
RVP, Rapid ventricular pacing; CMP, cardiomyoplasty; stim, stimulator; Ees, end-systolic elastance; PRSW, the slope of the preload recruitable stroke work 
line; dP/dt max and dP/dt rain, maximum and minimum rates of pressure change; LVP, left ventricular pressure; LVEDP, left ventricular end-diastolic 
pressure; Tau, the time constant of isovolumic pressure decay. All data are expressed as mean + standard eviation. For the control group, pressure-volume 
data are available for 9 of 11 dogs at 4 weeks of RVP. For the synchronous wrap group, volume data are available for 7 of 8 dogs at 4 weeks. 
*p Value by unpaired t-test comparing between control and synchronous wrap groups at ten weeks. 
?The delta columns express the percent change of a hemodynamic variable from four weeks to ten weeks RVP as a fraction of the its 4 week RVP value. 
,+p < 0.05 by repeated-measures analysis of variance followed by Bonferroni's multiple comparison procedure comparing 4 weeks' RVP versus 10 weeks' RVP 
within each group. 
§p < 0.1 by repeated-measures analysis of variance followed by Bonferroni's multiple comparison procedure comparing 4 weeks' RVP versus 10 weeks' RVP 
within each group. 
Table III. Pressure-volume analysis: Dynamic effects at ten weeks of pacing 
Ten weeks of RVP 
Stimulator Augmented Nonaugmented ANOVA 
Parameter off stim 1:2 beats stim 1:2 beats Stimulator 1:1 p value* 
Ees (mm Hg/ml) 1.80 ,+ 0.53 2.19 .+ 0.69 1.97 _+ 0.68 2.49 _+ 0.58* 0.009 
PRSW (mm Hg) 31.3 --- 5.9 40.6 .+ 10.8" 34.5 ,+ 12.1 45.4 _+ 11.0" 0.004 
dP/dt max (ram Hg/sec) 985 ,+ 230 1003 ,+ 266 934 ,+ 253 1034 .+ 234 0.40 
Stroke work (ram Hg • ml) 1416 + 539 1707 _+ 973 1308 .+ 561 1648 .+ 724 0.06 
Peak LVP (mm Hg) 84.1 ,+ 11.2 85.2 _+ 10.4 81.0 _+ 10.1 84.6 _+ 6.5 0.55 
Heart rate (beats/min) 115.2 ,+ 20.2 115.6 .+ 17.9 115.3 _+ 19.4 116.2 +_ 18.6 0.98 
Tau (mscc) 66.6 + 26.5 67.4 ,+ 29.3 61.1 _+ 21.7 59.0 _+ 19.1 0.41 
dP/dt min (ram Hg/sec) -1123 ,+ 310 -1168 ,+ 311 -1140 ,+ 298 -1238 .+ 266 0.45 
LVEDP (ram Hg) 11.2 --- 8.2 9.0 _+ 4.3 8.6 _+ 4.4 9.8 ,+ 5.1 0.11 
RVP, Rapid ventricular pacing; Ees, end-systolic elastance; PRSW, the slope of the preload recruitable stroke work line; dP/dt max and dP/dt min, maximum 
and minimum rates of pressure change; LVP, left ventricular pressure; LVEDP, left ventricular end-diastolic pressure; Tau, the time constant of isovolumic 
pressure decay. All data are expressed as mean -+ standard eviation. Data for the 1:2 beats are analyzed separately for augmented and nonaugmented beats. 
N = 8 dynamic CMP dogs 
*p < 0.05 by Dunnett's multiple comparison procedue following the repeated-measures analysis of variance comparing stimulator on settings versus 
stimulator "off." 
candy elevated by 4 weeks of rapid ventricular 
pacing in the synchronous wrap group (furosemide 
withheld only morning of 4-week study/cardiomyo- 
plasty in the cardiomyoplasty group, but withheld 
morning before and morning of 4-week study in 
controls). However, the load-independent EDPVR 
shows similar diastolic reep (i.e., rightward shift of 
the EDPVR) in both groups. Echocardiographic 
data (see Fig. 2) also showed asignificant increase of 
volumes and a significant decrease of ejection frac- 
tion by 4 weeks of rapid ventricular pacing in both 
groups. No statistically significant difference could 
be detected between groups. 
Two of the 11 dogs in the control group had no 
pressure-volume analysis data at the 4-week time 
point. However, echocardiographic data from those 
two dogs demonstrated end-diastolic volumes and 
ejection fractions within the range seen for the 
group. In addition, the single dog in the cardiomy- 
oplasty group that had no volume data at the 4-week 
time point had pressure and imaging data that were 
within the range seen for the group. 
By the end of the 10-week pacing period, pump 
performance continued to deteriorate in control 
animals. All parameters of systolic function were 
lower (end-systolic elastance, p = 0.1; PRSW, p = 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 114, Number 2 
Patel et al. 175 
0.006; maximum dP/dt, p = 0.04), and diastolic 
performance measures of LVEDP, minimum dP/dt, 
and tau were also significantly different (p < 0.05) 
from their 4-week time points (Table II). Echocar- 
diographic left ventricular volumes continued to 
show progressive nlargement (p = 0.005) and 
deterioration i ejection fraction (p < 0.001, Fig. 2). 
Finally, the composite ESPVR and EDPVR of 
control dogs also confirmed deteriorating pump 
performance and diastolic creep (see Fig. 3, A). 
In contrast, the results from the cardiomyoplasty 
group show chronic stabilization of pump function. 
All data for assessment of chronic effects of cardio- 
myoplasty were performed with the myostimulator 
off. In addition, end-systolic elastance improved by 
10 weeks of rapid ventricular pacing and was signif- 
icantly different from control values at that time 
(p = 0,005). PRSW also stabilized in the wrap 
group, and the difference from control values at 10 
weeks was also significant (p = 0.05). L0ad-sensitive 
measures of contractility (maximum dP/dt and peak 
left ventricular pressures) stabilized in the cardio- 
myoplasty group. Diastolic performance showed ev- 
idence of stabilization when measured by the load- 
sensitive parameter of minimum dP/dt (see Table 
II). End-diastolic pressures and tau increased in the 
cardiomyoplasty group (as a result of different di- 
uretic management as stated earlier), as 
The final 6 weeks of rapid ventricular pacing also 
showed a persistent rightward shift in the composite 
ESPVR, along with continued iastolic reep in con- 
trol animals (Fig. 3, A). Similarly, an increase in 
ventricular volumes and a decrease inejection fraction 
was obtained by echocardiography (end-diastolic vol- 
ume, ejection fraction, p < 0.01, Fig. 2). In contrast, 
dynamic ardiomyoplasty not only stabilized echocar- 
diQgraphic volume and ejection fraction (end-diastolic 
volume, ejection fraction, p > 0.5, Fig. 2) but also 
maintained the composite ESPVR and EDPVR 
curves at their 4-week positions (Fig. 3, B). 
Pressurewolume data were also obtained with the 
myostimulator atthe 1:2 muscle/heartbeat r io and 
1:1 settings to assess acute dynamic effects of car- 
diomyoplasty (Table III). Load-independent i dices 
of end-systolic elastance and PRSW for the 1:1 beats 
demonstrate dynamic assistance (p < 0.05), and 
similar results are seen for the augmented 1:2 beats 
(PRSW, p < 0.05). Stroke work was also marginally 
greater for these beats. Although no significant 
difference was noted in diastolic indices (minimum 
dP/dt and LVEDP), nonetheless all values for these 
assisted beats improved. The nonaugmented 1:2 
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Fig. 4. Effect of dynamic assistance on the pressure- 
volume relationships in heart failure. Typical results are 
depicted for one dog during dynamic assistance for every 
beat (stimulator 1:1, solid lines) in comparison with unas- 
sisted beats (stimulator "off," dotted lines). Stroke work 
and the EDPVR do not change significantly for the 
assisted beats. Similarly, the position of the ESPVR and 
the pressure-volume loops do not change. However, a 
change in the end-systolic elastance (the slope of the 
ESPVR) for the assisted beats is evident when compared 
with unassisted beats. Our composite ESPVRs and ED- 
PVRs (not shown) comparing assisted 1:1 and 1:2 beats 
versus unassisted beats show similar results. This is an 
increase in effective contractility with skeletal muscle 
assistance. Because the stroke work (area within the 
pressure-volume lo0p) is not changed with assistance, 
myocardial workload is therefore decreased espite an 
increase in effective contractility. 
beats showed no difference in function when com- 
pared with myostimulator "off" settings. Finally, 
there was no change in the volume axis position of 
the composite ESPVRs for the assisted beats when 
compared with unassisted beats (data not shown). A 
representative xample, from one dog, of the 
changes in the pressure-volume relations and pres- 
sure-volume loops brought on by skeletal muscle 
assistance, is shown in Fig. 4. 
Discussion 
Dynamic cardiomyoplasty is a poorly understood 
surgical treatment for end-stage heart failure. Pa- 
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Dynamic cardiomyoplasty 
Limit left ventricular volume 
-reduce chronic dilation 
-decrease diastolic strain 
Enhance systolic performance 
-decrease myocardial workload 
-decrease cardiac oxygen consumption 
-improve myocardial efficiency 
Stabilize cardiac function 
Fig. 5. Proposed mechanisms of cardiomyoplasty. Dynamic ardiomyoplasty acts by at least two mecha- 
nisms. Girdling effects on the left ventricle limit the chronic dilation associated with heart failure and thus 
decrease diastolic strain. Enhancement of effective contractility with skeletal muscle assistance decreases 
myocardial workload and thus decreases cardiac oxygen consumption and increases myocardial efficiency. 
Both of these effects presumably act to stabilize cardiac function over time. 
tients receiving this treatment typically exhibit im- 
provement in symptoms, but consistent objective 
improvement in traditional indices 'of cardiac func- 
tion in these same patients is sometimes lacking. 1-17 
Postulated mechanisms of action include both acute 
systolic assistance 6-14 and a passive girdling effect on 
the left ventricle)' 15-!7 We undertook this study to 
assess both effects on the left ventricle in a clinically 
relevant fashion, that is, with the use of a synchro- 
nized burst-stimulated conditioned muscle wrap in a 
model of chronic heart failure. 
Rapid ventricular pacing of dog hearts has been 
previously validated as a model of severe biventricu- 
lar dilated cardiomyopathy, morphologically, neuro- 
hormonally, and functionally. 21 Our model is a 
modification of the existing well-characterized 
model. Most reports use rapid ventricular pacing at 
levels of 240 to 260 beats/rain to create a dilated 
cardiomyopathy within 2 to 4 weeks. When pacing is 
continued for protracted periods at this level, the 
mortality rate is significant. Our modification was a 
decrease in the pacing rate to 215 beats/min to 
create this model by 4 weeks of rapid ventricular 
pacing. This change, however, also allowed us to 
maintain the rapid pacing for 10 weeks so that 
conditioning of the muscle wrap and the final study 
could occur in the setting of heart failure. Assess- 
ment of cardiac function in our study included 
traditional imaging methods (echocardiography), 
along with pressure-volume analysis to obtain load- 
independent assessments of function. 
Our results show that in the setting of chronic 
severe heart failure, cardiomyoplasty affects cardiac 
function by at least two mechanisms (Fig. 5). Long- 
term effects of cardiomyoplasty include an attenua- 
tion of the ventricular enlargement and the remod- 
eling process that results in heart failure. Girdling 
effects have been demonstrated in several other 
recent studies. 3'15-17 Remodeling was demonstrated 
in our study by a rightward shift in composite 
ESPVR and EDPVR in control hearts throughout 
the rapid pacing period. This is an expected finding, 
because progressive left ventricular dilation is a 
common feature of severe congestive heart failure 
and is accompanied by rightward shifts of both the 
ESPVR and the EDPVR. Girdling effects in our 
study are demonstrated bya lack of rightward shifts 
in the pressure-volume r lations after cardiomyo- 
plasty, despite ongoing rapid pacing. Chronic over- 
loading of the heart, as seen in dilated cardiomyop- 
athy, leads to progression of heart failure and 
remodeling. B° This is associated with alterations of 
the extracellular matrix, myocyte cytoskeletal ar- 
rangements, myocyte alignment, and contractile 
protein orientation, all of which change myocyte 
geometry and function. TM 3o It is possible that the 
presence of additional imiting structures around 
the heart with a low elastance, such as the condi- 
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tioned muscle wrap, has decreased these processes 
to stop the progressive dilation seen in heart failure. 
Chronic effects may also be partly due to the 
phenotypic hanges that occur during electrical 
transformation f the skeletal muscle wrap. 4' 5; 18, 19 
Transformation f skeletal muscle has been shown 
to decrease muscle mass, area, and fiber caliber. 
This wrap may act like a volume-stabilizing girdle, 
because it shrinks around the heart during the 
process of transformation from type II to type I 
fibers. This shrinkage, which has been considered an 
undesirable side effect of muscle transformation, 
may play a larger ole in the improvement seen after 
cardiomyoplasty than previously thought. 
Cardiomyoplasty also appears to act dynamically 
to increase the apparent contractile state of the 
heart (see Figs. 4 and 5). Skeletal muscle assistance 
was shown in Jatene's eries 6of 13 patients. Cho, 8 
Aklog, 9 and their colleagues have shown augmenta- 
tion of elastance for assisted beats in normal hearts. 
Other reports have shown improvement in hemody- 
namics with synchronized stimulation optimiza- 
tion. 12 In addition, several recent studies have dem- 
onstrated ecreased wall stress with added systolic 
compression.10, 11 In our study on cardiomyopathic 
hearts, both stimulator 1:2 assisted and 1:1 beats 
showed an increase in load-independent i dices of 
contractility (end-systolic elastance and PRSW) 
when compared with stimulator "off" results. Com- 
posite ESPVRs and EDPVRs do not show a shift 
along the volume axis with dynamic assistance. Data 
from a typical dog (see Fig. 4) show an increase in 
the slope of the ESPVR, with minimal change in the 
EDPVR, the pressure-volume loop, or the position 
along the volume axis of the ESPVR with skeletal 
muscle stimulation. This implies a decrease in the 
myocardial workload, because the added effective 
contractility ielding a similar amount of stroke 
work is due to the skeletal muscle contraction. 
In summary, our study assessed both chronic and 
dynamic effects of a synchronized stimulated muscle 
wrap in a model of severe heart failure, We con- 
clude (see Fig. 5) that the presence of a transformed 
muscle wrap in cardiomyoplasty attenuates both 
ventricular dilation and the remodeling process as- 
sociated with severe progressive heart failure. We 
also believe that cardiomyoplasty acts by an acute 
dynamic process by increasing apparent contractility 
and by decreasing myocardial workload. 
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Appendix 
Generation of the composite ESPVRs and EDPVRs. The 
ESPVRs were obtained by using each dog's individual 
end-systolic elastance (Ees) along with its volume inter- 
cept (Vo). End-systolic volumes (Ves) for the composite 
ESPVR were then obtained from a preset range of 5 mm 
Hg increments of end-systolic pressures (Pes) using the 
equation: 
Ves = (Pes/Ees) + V0. 
End-systolic volumes were then averaged at each selected 
pressure for the composite ESPVR. The range of pres- 
sures was obtained from the range seen during typical 
preload reduction. 
Similarly, EDPVRs were constructed by determining 
the end-diastolic pressures (Ped) from 5 ml increments of 
a range of end-diastolic volumes (Ved). The EDPVR was 
fit to a monoexponential equation: 
Ped = P0 + a (e bred q- 1) 
where Po, a and b are the constants obtained from each 
dog at each time point, and e is the base of the natural 
logarithm. End-diastolic pressures from each volume in- 
crement were then averaged to obtain the composite 
EDPVR.  The preset volume range was determined by 
using those points where pressure was calculated to be 
within the range seen during preload reduction. 
